Search
for
Sort by
Research 91–120 of 1000+
- A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Erosive pustular dermatosis of the scalp due to EGFR inhibitors: A multicentric study by EADV task force of ‘Dermatology for Cancer Patients’
- Folliculitis Decalvans-like Alopecia During Treatment With EGFR Inhibitors for Lung Cancer: A Case Series of 6 Patients
- Síndrome PRIDE: una práctica forma de identificar los efectos adversos cutáneos de los inhibidores del EGFR
- 422 Human hair follicles express PD-L1, whose expression is down-regulated by EGFR and MEK inhibitors ex vivo. A potential mechanism for EGFR inhibitor induced sterile folliculitis
- Clinical development and management of adverse events associated with FGFR inhibitors
- Cutaneous side-effects of EGFR inhibitors and their management.
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Ethanol Enhances Neurosteroidogenesis in Hippocampal Pyramidal Neurons by Paradoxical NMDA Receptor Activation
- Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride
- In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5α-reductase inhibitors
- Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
- Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia
- 11β-Hydroxylase inhibitors protect against seizures in mice by increasing endogenous neurosteroid synthesis
- AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells
- Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- Network pharmacology and molecular docking analysis on potential molecular targets and mechanism of action of BRAF inhibitors for application in wound healing
- Network pharmacology-based preventive effect of XZF on cutaneous toxicities induced by EGFR inhibitor
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
- Impact of CDK4/6 inhibitors on health-related quality of life outcomes in patients with metastatic breast cancer: A systematic review and meta-analysis
- EFFECTS OF FESOTERODINE, A NOVEL ANTIMUSCARINIC, ALONE AND IN COMBINATION WITH AN α-RECEPTOR BLOCKER, DOXAZOSIN, ON BLADDER FUNCTION IN OBSTRUCTED RATS
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- Androgens inhibit phagocytosis by macrophages via the androgen receptor in vitro
- ISID1338 - Epidermal growth factor receptor protects from immune privilege collapse and scarring hair follicle destruction